References
- Goodwin C. S., Armstrong J. A., Chilvers T., et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int J Syst Bacteriol 1989; 39: 397–405
- Axon A. R. Duodenal ulcer: the villain unmasked?. Br Med J 1991; 302: 919–21
- Drumm B. Helicobacter pylori. Arch Dis Childh 1990; 65: 1278–82
- Drumm B., Perez-Perez G. I., Blaser M. J., Sherman P. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med 1990; 322: 359–63
- Drumm B., Sherman P., Cutz E., Karmali M. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987; 316: 1557–61
- Drumm B., O'Brien A., Cutz E., Sherman P. Campylobacter pyloridis-assotiated primary gastritis in children. Pediatrics 1987; 80: 192–5
- Drumm B., Sherman P., Chiasson D., Karmali M., Cutz E. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin. J Pediatr 1988; 113: 980–12
- Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Austr 1985; 142: 436–9
- Morris A., Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–9
- Fox J. G., Lee A. Gastric campylobacter-like organisms: their role in gastric disease in laboratory animals. Lab Anim Sci 1989; 39: 543–53
- Rauws E. A J, Tytgat G. N J. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–5
- George L. L., Borody T. J., Andrews P., et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Austr 1990; 153: 145–9
- Elta G. H. Duodenal ulcer disease–to heal or to cure? ‘selected summary’. Gastroenterology 1991; 100: 573–5
- Mainguet P., Delmee M., Debongnie J. C. Omeprazole, Campylobacter pylori, and duodenal ulcer ‘letter’. Lancet 1989; 2: 389–90
- Bisco G., Miglioli M., Barbara L., Corinaldesi R., DiFebo G. Omeprazole, Helicobacter pylori, gastritis and duodenal ulcer ‘letter’. Lancet 1989; 2: 1403
- Hui W. M., Lam S. K., Ho J., et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991; 36: 577–82
- Unge P., Gad A., Gnarpe H., Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis?. Scand J Gastroenterol 1989; 24(Suppl 167)49–54
- Rauws E. A J, Langenberg W., Bosma A., Dankert J., Tytgat G. N J. Lack of eradication of Helicobacter pylori after omeprazole ‘letter’. Lancet 1991; 337: 1093
- Simor A. E., Shames B., Drumm B., Sherman P., Low D., Penner J. Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol 1990; 28: 83–6
- Shames B., Krajden S., Fuksa M., Babida C., Penner J. L. Evidence for occurrence of the same strain of Campylobacter pylori in the stomach and dental plaque. J Clin Microbiol 1989; 27: 2849–50
- Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning. A laboratory manual2nd ed. Laboratory Press, Cold Spring Harbor 1989
- Sahm D. F., Washington J. A. Antibacterial susceptibility tests: dilution methods. Manual of clinical microbiology5th ed., A. Balows, W. J. Hausler, K. L. Herrmann, H. D. Isenberg, H. J. Shadomy. ASM Press, Washington 1991; 1105–16
- Iwahi T., Satoh H., Nakao M., et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against. Helicobacter pylori Anti-microb Agents Chemother 1991; 35: 490–6
- Megraud F., Boyanova L., Lamouliatte H. Activity of lansoprazole against. Helicobacter pylori ‘letter’. Lancet 1991; 337: 1486
- Ghelani A. M., Hale S., Coleman H., Radziwonik H., Robertson C., Atkinson M. Lack of in vitro activity of omeprazole against Campylobacter pylori ‘letter’. J Clin Pathol 1990; 43: 171–2
- McNulty C. A M, Gearty J. C., Crump B., et al. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethyl-succinate. Br Med J 1986; 293: 645–9
- Westblom T. U., Duriex D. E. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against. Helicobacter pylori Micro-biologica 1991; 14: 37–43
- McNulty C. A M, Dent J. C., Ford G. A., Wilkinson S. P. Inhibitory antimicrobial concentrations against. Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22: 729–38
- Glupczynski Y., Burette A., DeKoster E., et al. Metronidazole resistance in Helicobacter pylori ‘letter’. Lancet 1990; 1: 976–7
- Bell G. D. Anti-Helicobacter pylori therapy: clearance, elimination, or eradication? ‘letter’. Lancet 1991; 337: 310–1
- Maton P. N. Omeprazole. N Engl J Med 1991; 324: 965–75
- Sharma B. K., Santana I. A., Wood E. C., et al. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J 1984; 289: 717–9